Radiobiology and cancer

Ferran Guedea i Edo

PRINCIPAL INVESTIGATORS
  • Arturo Navarro Martin
  • Ferran Ferrer Gonzalez
  • Juan Luis Ribes Bernal
  • Isabel Linares Galiana
  • Miquel Macia Garau
  • Miguel Angel Berenguer Frances
  • Evelyn Martinez Perez
  • Maria Aranzazu Eraso Urién
  • Anna Maria Boladeras Inglada
  • Cristina Gutierrez Miguelez
CLINICAL RESEARCHERS
  • Joel Mases Rosines
  • Ines Guix Sauquet
  • Ignacio Visus Fernandez De Manzanos
  • Andrea Slocker Escarpa
  • Leyre Asiáin Azcárate
  • Maria Laplana Torres
  • Dina Najjari Jamal
  • Sonia Almendros Sanchez
  • Nagore Garcia Exposito
  • Héctor Pérez Montero
  • Miriam Nuñez Fernandez
COLLABORATORS
  • Silvia Comas Anton
PREDOCTORAL RESEARCHERS (R1)
  • Mònica Pujol Canadell
SCIENTIFIC SUPPORT
  • Pilar Izquierdo Trigo
  • Rut Cañas Cortes
  • Montserrat Ventura Bujalance
Cancer
Oncobell

Scientific production

11

PAPERS

Selected publications

  • Casas, F; Valduvieco, I; Oses, G; Izquierdo, L; Archila, I; Costa, M; Cortes, KS; Barreto, T; Ferrer, F. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival. CLINICAL AND TRANSLATIONAL ONCOLOGY. 10.1007/s12094-018-1931-3
  • Cozzi S, Jamal DN, Slocker A, Laplana M, Tejedor AG, Krengli M, Guedea F, Gutierrez C . Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients.. JOURNAL OF CONTEMPORARY BRACHYTHERAPY. 10.5114/jcb.2019.84689
  • Almendros S., Berenguer-Francés M., Ferrer-González F., Boladeras A., Guix I., Guedea F.. Predictive factors for abiraterone withdrawal syndrome [Factores predictivos del síndrome de retirada de abiraterona]. ACTAS UROLOGICAS ESPANOLAS. 10.1016/j.acuro.2019.01.003

Research highlights

PROJECTS

1 Ongoing project

3 Ongoing clinical trials

PUBLISHED WORKS

2 Clinical guidelines

1 Thesis

Selected projects

  • Estudio de fase 3 aleatorizado, doble ciego y controlado con placebo de JNJ-56021927 en sujetos con cáncer de próstata localizado o localmente avanzado y de alto riesgo que están recibiendo tratamiento con radioterapia primaria (4/3/2016 – ) PI: BOLADERAS INGLADA, ANNA MARIA. Funder ref.: 56021927PCR3003.